PHARMABRIDGE, INC.

Basic Information

3805 OLD EASTON ROAD
DOYLESTOWN, PA, -

Company Profile

n/a

Additional Details

Field Value
DUNS: 787949390
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection

    Amount: $3,000,000.00

    DESCRIPTION (provided by applicant): This is a Phase II proposal to advance development of disubstituted tetrahydro-triazolo-pyrimidines (TTPs) as specific inhibitors of hepatitis B virus surface anti ...

    SBIR Phase II 2011 Department of Health and Human Services
  2. Novel HBV Therapeutic with Potential for Treatment of Drug-Resistant Infection

    Amount: $240,146.00

    DESCRIPTION (provided by applicant): Our proposal centers on the development of a novel antiviral compound for therapy of hepatitis B patients. Hepatitis B surface antigen (HBsAg) is an essential vira ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government